20
Aug

AstraZeneca’s antibiotic combination treatment beat out standard meropenem in treating complicated infections, the company said, setting the table for a near-term shot at regulatory approval.

…read more

Source: AstraZeneca’s new antibiotic comes through in Phase III

    

0 No comments